REVANESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Revanesse Pure™+
Revanesse Pure+ is a colourless, odourless, transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada. It carries hyaluronic acid at 14 mg/mL with 0.3% lidocaine in phosphate-buffered saline. It is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin, with an implantation life averaging 4 weeks. Each box contains two 1.2 mL syringes with up to two sterilised 27G needles.
Key Benefits of Revanesse Pure™+
- Hyaluronic acid 14 mg/mL, one of the two lightest concentrations in the Revanesse range
- 0.3% lidocaine for injection comfort
- Placed at the most superficial layer of the skin
- Indicated for facial rhytides and lipoatrophy
- Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
- Implantation life averages 4 weeks, suiting a repeated skin-quality regimen
- CE marked 0653 for the syringe, with CE 0123 needles
Indications and Professional Use
Main indications
- Facial rhytides
- Lipoatrophy
Professional use
For professional use. Revanesse Pure+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is injected into the skin at its most superficial layer; the manufacturer notes that injection depth, treatment areas and indications may differ by country, region or territory and are determined by the treating practitioner. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.
Treatment areas
- Face
Patient profile
For adult patients seeking treatment of facial rhytides or lipoatrophy at skin level, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.
How Revanesse Pure™+ Works
Revanesse Pure+ works at the skin rather than in the deeper planes the cross-linked references occupy. At 14 mg/mL, it carries roughly half the hyaluronic acid of the 25 mg/mL volumising grades, and it is placed in the most superficial layer of the skin, which is why its stated implantation life is around 4 weeks rather than the 6 to 12 months of the volumising references. It is a treatment to be repeated as part of a skin-quality regimen rather than a single volumising correction, and the 0.3% lidocaine is present for injection comfort.
Why Order From Allpara
Allpara offers genuine, verified REVANESSE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Pure+ differ from Revanesse Renew+?
On the manufacturer's own figures they share a specification: 14 mg/mL hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes, placed at the most superficial layer of the skin for facial rhytides and lipoatrophy, with an implantation life averaging 4 weeks. Pure+ has its needle gauge stated as 27G.
Why does Pure+ last so much less time than the other Revanesse references?
Because it does a different job. At 14 mg/mL placed at the most superficial layer of the skin, its stated implantation life averages 4 weeks, against 6 to 12 months for the 25 mg/mL volumising references placed in the dermis. It is intended as a repeatable skin-quality treatment rather than a single volumising correction.
Where can clinics buy Revanesse Pure+?
ALLPARA supplies Revanesse Pure+ to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Prollenium Medical Technologies
Clinic alternatives
Pick up where you left off
Revanesse Pure™+
Revanesse Pure+ is a colourless, odourless, transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada. It carries hyaluronic acid at 14 mg/mL with 0.3% lidocaine in phosphate-buffered saline. It is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin, with an implantation life averaging 4 weeks. Each box contains two 1.2 mL syringes with up to two sterilised 27G needles.
Key Benefits of Revanesse Pure™+
- Hyaluronic acid 14 mg/mL, one of the two lightest concentrations in the Revanesse range
- 0.3% lidocaine for injection comfort
- Placed at the most superficial layer of the skin
- Indicated for facial rhytides and lipoatrophy
- Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
- Implantation life averages 4 weeks, suiting a repeated skin-quality regimen
- CE marked 0653 for the syringe, with CE 0123 needles
Indications and Professional Use
Main indications
- Facial rhytides
- Lipoatrophy
Professional use
For professional use. Revanesse Pure+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is injected into the skin at its most superficial layer; the manufacturer notes that injection depth, treatment areas and indications may differ by country, region or territory and are determined by the treating practitioner. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.
Treatment areas
- Face
Patient profile
For adult patients seeking treatment of facial rhytides or lipoatrophy at skin level, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.
How Revanesse Pure™+ Works
Revanesse Pure+ works at the skin rather than in the deeper planes the cross-linked references occupy. At 14 mg/mL, it carries roughly half the hyaluronic acid of the 25 mg/mL volumising grades, and it is placed in the most superficial layer of the skin, which is why its stated implantation life is around 4 weeks rather than the 6 to 12 months of the volumising references. It is a treatment to be repeated as part of a skin-quality regimen rather than a single volumising correction, and the 0.3% lidocaine is present for injection comfort.
Why Order From Allpara
Allpara offers genuine, verified REVANESSE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Pure+ differ from Revanesse Renew+?
On the manufacturer's own figures they share a specification: 14 mg/mL hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes, placed at the most superficial layer of the skin for facial rhytides and lipoatrophy, with an implantation life averaging 4 weeks. Pure+ has its needle gauge stated as 27G.
Why does Pure+ last so much less time than the other Revanesse references?
Because it does a different job. At 14 mg/mL placed at the most superficial layer of the skin, its stated implantation life averages 4 weeks, against 6 to 12 months for the 25 mg/mL volumising references placed in the dermis. It is intended as a repeatable skin-quality treatment rather than a single volumising correction.
Where can clinics buy Revanesse Pure+?
ALLPARA supplies Revanesse Pure+ to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.